<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>临床研究观潮 | wechat-feeds</title><link>http://MzIxMjE1NDc0OQ.favicon.privacyhide.com/favicon.ico</link><description>介绍大药厂临床试验、国内创新药动态、FDA\EMA\PMDA等法规指南、药物评审报告、行业潜力分析，组织焦点讨论或会议，深度挖掘临床试验数据本质意义；服务于试验机构、PM、CRO以及CRA\CRC。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 10 Feb 2021 23:44:00 +0800</pubDate><image><url>http://MzIxMjE1NDc0OQ.favicon.privacyhide.com/favicon.ico</url><title>临床研究观潮 | wechat-feeds</title><link>http://MzIxMjE1NDc0OQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>FDA-临床药理学可以做什么（12）MIDD模型引导的药物开发</title><link>https://mp.weixin.qq.com/s/qoeKRbLegtL0nY7aVcYSBw</link><description></description><content:encoded><![CDATA[FDA-临床药理学可以做什么（12）MIDD模型引导的药物开发]]></content:encoded><pubDate>Wed, 10 Feb 2021 23:40:45 +0800</pubDate></item><item><title>FDA-临床药理学可以做什么（11）-FDA如何审评资料</title><link>https://mp.weixin.qq.com/s/y8hjNCd_ey799GyJkbR4vw</link><description></description><content:encoded><![CDATA[FDA-临床药理学可以做什么（11）-FDA如何审评资料]]></content:encoded><pubDate>Sun, 07 Feb 2021 19:56:10 +0800</pubDate></item><item><title>临床试验方案撰写神器</title><link>https://mp.weixin.qq.com/s/Q_NNA-J6KL6VFW-ZxLQlMg</link><description></description><content:encoded><![CDATA[临床试验方案撰写神器]]></content:encoded><pubDate>Fri, 05 Feb 2021 19:25:31 +0800</pubDate></item><item><title>群体药代数据结构和数据标准</title><link>https://mp.weixin.qq.com/s/JnyseiU2OD-eHcvTZ2QYuQ</link><description></description><content:encoded><![CDATA[群体药代数据结构和数据标准]]></content:encoded><pubDate>Mon, 25 Jan 2021 18:40:55 +0800</pubDate></item><item><title>一招必胜的绝技，送给2021的牛气冲天</title><link>https://mp.weixin.qq.com/s/keiDXT0d2yFOxDlp-ix41A</link><description></description><content:encoded><![CDATA[一招必胜的绝技，送给2021的牛气冲天]]></content:encoded><pubDate>Thu, 31 Dec 2020 21:27:26 +0800</pubDate></item><item><title>桥接临床试验在日本怎么做</title><link>https://mp.weixin.qq.com/s/FHbevyonour3s4yT0mIK1g</link><description></description><content:encoded><![CDATA[桥接临床试验在日本怎么做]]></content:encoded><pubDate>Sat, 26 Dec 2020 23:00:33 +0800</pubDate></item><item><title>popPK &amp; PK-NCA数据标准</title><link>https://mp.weixin.qq.com/s/5bdfqcfZQChFfRIisTotuA</link><description></description><content:encoded><![CDATA[popPK & PK-NCA数据标准]]></content:encoded><pubDate>Sat, 26 Dec 2020 22:29:56 +0800</pubDate></item><item><title>临床试验守住底线</title><link>https://mp.weixin.qq.com/s/zraQT8WTyh0P5TDtlCdrjQ</link><description></description><content:encoded><![CDATA[临床试验守住底线]]></content:encoded><pubDate>Fri, 25 Dec 2020 22:00:38 +0800</pubDate></item><item><title>推荐R语言一个包：ggplot2神器esquisse</title><link>https://mp.weixin.qq.com/s/spVUveuZOvJ9InITASSz6A</link><description></description><content:encoded><![CDATA[推荐R语言一个包：ggplot2神器esquisse]]></content:encoded><pubDate>Thu, 03 Dec 2020 21:50:07 +0800</pubDate></item><item><title>说明书如何撰写-临床药理学部分</title><link>https://mp.weixin.qq.com/s/CwNVuK0ZUlSkor3EYvLNpA</link><description></description><content:encoded><![CDATA[说明书如何撰写-临床药理学部分]]></content:encoded><pubDate>Mon, 23 Nov 2020 18:10:31 +0800</pubDate></item></channel></rss>